Cargando…
Mitra-clip in Transthyretin Amyloidosis Cardiomyopathy A Case Series
INTRODUCTION: Non-invasive valvular interventions have dramatically changed the management of patients with multiple complex comorbidities. Patients with cardiac amyloidosis (CA) are often considered high-risk for surgical intervention. Trans-catheter aortic valve replacement (TAVR) is tolerated in...
Autores principales: | Cuddy, Sarah, Dorbala, Sharmila, Falk, Rodney |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527167/ http://dx.doi.org/10.1016/j.cardfail.2020.09.464 |
Ejemplares similares
-
Long COVID-19 chez des patients Nord-Africains : l’incapacité évaluée par les données du test de marche de six minutes
por: Derbel, K., et al.
Publicado: (2022) -
Effect of Tafamidis on Serum Transthyretin Levels in Non-Trial Patients With Transthyretin Amyloid Cardiomyopathy
por: Falk, Rodney H., et al.
Publicado: (2021) -
Effect of tafamidis on global longitudinal strain and myocardial work in transthyretin cardiac amyloidosis
por: Giblin, Gerard T, et al.
Publicado: (2022) -
Modeling the Cost and Health Impacts of Diagnostic Strategies in Patients with Suspected Transthyretin Cardiac Amyloidosis
por: Ge, Yin, et al.
Publicado: (2022) -
Transthyretin Cardiac Amyloidosis: Underrecognized in the Underrepresented
por: Leedy, Douglas J., et al.
Publicado: (2023)